8-K

Company

Nurix Therapeutics, Inc.

Filed

September 3, 2025

Period of Report

September 3, 2025

Accession Number

0001549595-25-000108

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →